Form 4: Boston Scientific Executive Reports Stock Transaction

John Bradley Sorenson, EVP of Global Operations at Boston Scientific, reported a transaction involving 2,610 shares of common stock.

Summary

• John Bradley Sorenson, an Executive Vice President at Boston Scientific, filed a Form 4 indicating a transaction involving the company's common stock.
• The transaction occurred on November 12, 2024, and involved the acquisition of 2,610 shares.
• These shares were acquired at a price of $0.00, suggesting they were likely granted as part of a compensation package.
• Following this transaction, Sorenson's total direct holdings in Boston Scientific common stock amount to 37,096 shares.

Sentiment

Score: 7

Explanation: The document is a routine filing related to executive stock transactions, which is neither positive nor negative for the company's overall performance. It is a neutral event.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock ownership of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The transaction is typical of executive compensation packages, which often include stock grants.
• The reporting requirements are consistent across all companies listed on US exchanges.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in executive ownership, but is not a market transaction.

Key Dates

Keywords

Form 4, Boston Scientific, Stock Transaction, Executive Compensation, Beneficial Ownership, BSX, Sorenson